MON-LB079 A Multicenter, Randomized, Open-Label, Phase IV Study Investigating Management of Pasireotide-Associated Hyperglycemia with Incretin-Based Therapy or Insulin in Patients with Acromegaly or Cushing's Disease (CD)

Background: Pasireotide has proven efficacy in acromegaly and CD, although pasireotide-associated hyperglycemia occurs in some patients (pts). We present results from a Phase IV, randomized, open-label study investigating optimal management of pasireotide-associated hyperglycemia uncontrolled by met...

Descripción completa

Detalles Bibliográficos
Autores principales: Samson, Susan, Gu, Feng, Feldt-Rasmussen, Ulla, Zhang, Shaoling, Yu, Yerong, Witek, Przemyslaw, Pedroncelli, Alberto, Nauwelaerts, Heidi, Jabbour, Nadine, Paul, Michaela, Bolanowski, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550842/
http://dx.doi.org/10.1210/js.2019-MON-LB079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550842/
http://dx.doi.org/10.1210/js.2019-MON-LB079

Ejemplares similares